HIV multidrug class resistance prediction with a time sliding anchor approach.
Journal:
Bioinformatics advances
Published Date:
Jan 1, 2025
Abstract
MOTIVATION: The emergence of multidrug class resistance (MDR) in Human Immunodeficiency Virus (HIV) is a rare but significant challenge in antiretroviral therapy (ART). MDR, which may arise from prolonged drug exposure, treatment failures, or transmission of resistant strains, accelerates disease progression and poses particular challenges in resource-limited settings with restricted access to resistance testing and advanced therapies. Early prediction of future MDR development is important to inform therapeutic decisions and mitigate its occurrence.
Authors
Keywords
No keywords available for this article.